This session will provide guidance and some practical considerations around the importance of selecting the optimum re-supply strategy in studies with multiple drug assignments. Patient safety is directly impacted by the availability of treatment when a patient arrives at the investigator site. To ensure that patients have access to the necessary treatment at the time required, it is imperative to have a re-supply strategy that takes into account both patient and site needs, as well as, cost-effective inventory levels.
The presentation will compare the advantages and disadvantages of two different re-supply strategies, in the context of patient safety and inventory management. The dynamic (predictive) re-supply strategy focuses on site and patient needs. The static (pre-set min/max trigger levels) re-supply strategy is easy to understand but relies on enrollment assumptions. The re-supply strategy can be given an extra layer of intelligence by including factors not immediately linked to actual patient needs, but which focus instead on distribution requirements. This includes, but is not limited to, the maximum amount of drug a site can store, minimum shipment quantities, etc.
This audio conference will cover:
- Detail critical pre-study planning considerations
- Review the advantages and disadvantages of a static vs. dynamic re-supply strategy
- Discuss the impact of re-supply strategy on patient safety
- Provide the top 5 re-supply recommendations
- Identify inventory management benefits of utilizing an IVR
About the speaker:
Geert Langendries currently serves as Director within the Covance IVRS Project Management group. He provides advice, expertise, and consultancy to IVRS clients and is responsible for project management in IVRS project startup and maintenance, serving as a key contact for Sponsors on new and existing projects, monitoring timelines, budgets, and activities for active systems. Geert has been with Covance for 8 years, and began his career with the company as a IVRS Project Assistant in Brussels, Belgium.
Who should attend?
- Clinical Trials Supply, Logistics, Operations & Purchasing
- Clinical Manufacturing
- Clinical QA / QC
- Clinical Affairs
- Clinical Planning
- Drug Supply Management
- Investigational Supply
- Project Management
- Regulatory Affairs
This audio conference is classified as General Interest.